The company's personalized therapies use low energy, alternating magnetic field stimulation in daily 30-minute sessions to gently adjust a depressed brain toward a more normal state, enabling patients to quickly cure major depressive disorders and other diseases of the central nervous system. Led by experienced medical device executives and entrepreneurs, NeoSync's proprietary platform technology is being used to develop advanced, non-invasive neuromodulation products designed to treat a range of mental health disorders, including Autism, Parkinson's Disease, Anxiety, Post Traumatic Stress Disorder, and more.